The Technology

Medasense develops a pain-monitoring system, an innovative, patent-pending platform technology for automated and continuous assessment of a patient’s pain level. Medasense’s solution is based on a non-invasive acquisition of multiple patients’ physiological signals.

The acquired physiological data is analyzed by algorithms that use modern methods of biomedical signal processing, machine learning, and pattern recognition. Substantial technological and scientific progress has made this computationally demanding approach commercially feasible only recently. Outstanding performances achieved during a proof-of-concept trial have demonstrated the validity of the proposed solution.

Medasense’s first pain-monitoring prototype was successfully tested on 70 volunteers in feasibility trials at Rambam Health Care Campus, Haifa, Israel. It achieved outstanding performances. Clinical trials in operating rooms have just been approved by Rambam’s Helsinki committee. The pilot stage of the trial is scheduled for Q4 2009.

News

September, 2011:
Medasense Biometrics chosen to present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011

September, 2011:
Results of Medasense supported research were presented at "Pain in Europe VII", the 7th Congress of the European Federation of International Association for the Study of Pain Chapters

August, 2011:
Medasense Biometrics technology is featured in a newspaper article “Feel its pain: why the healthcare system doesn’t have a standard for measuring pain?” by Gali Weinreb, Globes, August 27th, 2011

June, 2011:
Medasense Biometrics has appeared on "The Landes Shortlist of Promising Israeli Technologies", by C. Wylie, Cell Cycle, Vol. 10, pp. 1887-1881.

May 2011:
Medasense to present at ILSI- Biomed Israel 2011 (Monday, May 23, 18:10 – 18:30)

December 2010:
OHV and Dr. Shmuel Cabilly invest in Medasense Biometrics

November 2010:
Results of Medasense supported research were presented on the annual conference of the Israel Pain Association

June 2010:
Medasense to present at Personalized Medicine World Conference 2010 Israel

December 2008:
Capital Point invests in Medasense Biometrics